75996-29-1

Basic information

• Product Name: 5-FLUOROBENZENE-1,3-DIOL
• Synonyms: 5-Fluororesorcinol
• CAS NO: 75996-29-1
• Molecular Formula: C₆H₅FO₂
• Molecular Weight: 128.1011032
• Mol File: 75996-29-1.mol
• Article Data: 18

Chemical Properties

• Melting Point: 136.0 to 140.0 °C
• Boiling Point: 237.878°C at 760 mmHg
• Flash Point: 97.665°C
• Appearance: /
• Density: 1.415g/cm³
• Vapor Pressure: 0.028mmHg at 25°C
• Refractive Index: 1.577
• Storage Temp.: Inert atmosphere,Room Temperature
• Water Solubility: Practically insoluble in water
• CAS DataBase Reference: 5-FLUOROBENZENE-1,3-DIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 5-FLUOROBENZENE-1,3-DIOL(75996-29-1)
• EPA Substance Registry System: 5-FLUOROBENZENE-1,3-DIOL(75996-29-1)

Safety Data

• Hazardous Substances Data: 75996-29-1(Hazardous Substances Data)

Usage

General Description

5-Fluorobenzene-1,3-diol, also known as fluororesorcinol, is a chemical compound that belongs to the class of benzene derivatives. It is a fluorinated form of resorcinol, which is commonly used in the production of pharmaceuticals, dyes, and other organic compounds. 5-Fluorobenzene-1,3-diol has been studied for its potential antitumor and antibacterial properties, making it a subject of interest in the field of medicinal chemistry. Its chemical structure and properties make it a versatile building block for the synthesis of various bioactive molecules. Additionally, the fluorine substituent in 5-fluorobenzene-1,3-diol makes it an interesting target for research in the fields of fluorine chemistry and organic synthesis.

InChI:InChI=1/C6H5FO2/c7-4-1-5(8)3-6(9)2-4/h1-3,8-9H

Upstream product

• 75996-26-8 azido(3,5-dimethoxyphenyl)methanone 
• 54132-76-2 3,5-dimethoxyphenyl isocyanate 
• 10272-07-8 3.5-dimethoxyaniline 
• 17213-57-9 3,5-dimethoxybenzoyl chloride 
• 1132-21-4 3,5-dimethoxybenzoic acid 
• 72470-95-2 3,5-dimethoxybenzenediazonium tetrafluoroborate 
• 51707-38-1 3,5-dimethoxy-benzoic acid hydrazide 
• 17213-58-0 3,5-dimethoxybenzamide 
• 99-10-5 3,5-Dihydroxybenzoic acid 
• 17275-82-0 ethyl 3,5-dimethoxybenzoate 
• 52189-63-6 3,5-dimethoxyfluorobenzene 

Downstream Products

• 1569070-66-1 C₂₈H₂₅FN₄O₄ 
• 1569071-04-0 C₁₇H₂₅FN₂O₂Si 
• 1569070-26-3 C₂₈H₂₄FN₃O₅*ClH 
• 1569070-23-0 C₂₈H₂₄FN₃O₄S*ClH 

Relevant articles and documents

Ferroelectric and antiferroelectric "banana phases" of new fluorinated five-ring bent-core mesogens

Two homologous achiral five-ring mesogens with lateral fluorine substituents on the core and on the outer rings are presented. Both compounds exhibit two B5 phases and the B2 phase. The high-temperature B5 phases possess an antiferroelectric ground state. The low-temperature B5 phase was found to be ferroelectric, which is indicated by the bistable switching. The assignment and characterization of the mesophases is based on XRD measurements, 1H-, 19F-, 13C-NMR and electro-optical measurements.

FLUORINATED 4' ALKYLUMBELLIFERYL α-D-GLUCOPYRANOSIDES, BIOLOGICAL STERILIZATION INDICATORS INCLUDING THE SAME AND METHODS OF USING THE SAME

A self-contained biological sterilization indicator comprises: a housing; bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate; and a frangible container containing a composition, wherein the composition comprises the enzyme substrate, wherein if the frangible container is broken the composition will contact the bacterial spores to form a mixture having an initial pH in the range from 6.0 to 9.0. The enzyme substrate comprises a fluorinated 4'-alkylumbelliferyl α-D-glucopyranoside represented by the structural formula (I) wherein one of R1 and R2 is F and the other is H, and R3 is an alkyl group having from 1 to 12 carbon atoms. A biological sterilization indicator comprising a kit containing isolated components comprising (i) bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of the enzyme substrate and a method of assessing efficacy of a sterilization process are also disclosed.

Preparation method and medicinal application of halogenated benzenediol glucoside

The invention discloses halogenated benzenediol glucoside with the structural formula as shown in the figure (I) in the specification, a preparation method for the compound and novel application of the compound and a pharmaceutical composition containing the compound in the aspect of inhibiting the inflammation of microgliacyte. (Please see the figure (I) in the specification for the structural formula of the halogenated benzenediol glucoside.).